Table 1 Baseline Characteristics by Bariatric Surgery Status.
From: The Effect of Bariatric Surgery on Hypertension Outcomes: A Retrospective Cohort Study
Characteristic | Overall N = 187 667 | Bariatric Surgery Ever N = 3 965 | No Bariatric Surgery N = 183 702 | P-Value |
---|---|---|---|---|
Age, years (SD) | 55 (11) | 54 (11) | 55 (12) | <0.001 |
Female, n (%) | 18 669 (10%) | 870 (22%) | 17 799 (10%) | <0.001 |
Race/Ethnicity, n (%) | ||||
Black Non-Hispanic | 32 679 (17%) | 723 (18%) | 31,956 (17%) | 0.001 |
White Non-Hispanic | 125 897 (67%) | 2 686 (68%) | 123 211 (67%) | |
Hispanic | 10 501 (6%) | 235 (6%) | 10 266 (6%) | |
Other or Unknown Race | 18 590 (10%) | 321 (8%) | 18 269 (10%) | |
BMI, kg/m2 (SD) | 39.3 (4.3) | 39.1 (4.4) | 39.3 (4.3) | <0.001 |
Systolic blood pressure, mm Hg (SD) | 140 (14) | 139 (14) | 140 (14) | <0.001 |
Diastolic blood pressure, mm Hg (SD) | 83 (10) | 82 (10) | 83 (10) | <0.001 |
Estimated glomerular filtration rate, mL/min/1.73m2* | 87 (19) | 89 (19) | 87 (19) | <0.001 |
Chronic kidney disease, n (%)† | 11 407 (6%) | 198 (5%) | 11 209 (6%) | <0.001 |
Diabetes mellitus, n (%) | 64 116 (34%) | 1 132 (29%) | 62 984 (34%) | <0.001 |
Cardiovascular disease, n (%) | 12 166 (6%) | 320 (8%) | 11 846 (6%) | <0.001 |
Heart failure, n (%) | 5 013 (3%) | 86 (2%) | 4 927 (3%) | 0.047 |
Arrhythmia, n (%) | 16 763 (9%) | 394 (10%) | 16 369 (9%) | 0.025 |
Peripheral artery disease, n (%) | 6 516 (3%) | 170 (4%) | 6 346 (3%) | 0.005 |
Obstructive sleep apnea, n (%) | 17 360 (9%) | 232 (6%) | 17 128 (9%) | <0.001 |
Metabolic dysfunction-associated steatotic liver disease, n (%) | 9 648 (5%) | 263 (7%) | 9 385 (5%) | <0.001 |
Current or prior smoker, n (%) | 48 714 (26%) | 1 025 (26%) | 47 689 (26%) | 0.877 |
Antihypertensive medications, n (SD) | 1.6 (0.9) | 1.5 (0.8) | 1.6 (0.9) | <0.001 |
Type of Bariatric Surgery, n (%) | ||||
Gastric Bypass | 499 (13%) | |||
Duodenal Switch | 593 (15%) | |||
Sleeve Gastrectomy | 215 (5%) | |||
Gastric Band | 27 (1%) | |||
Unknown Type | 2 631 (66%) |